These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis. Yoon HS; Kim HJ; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Kim JY; Lim YT; Bae KW; Lee KO; Shin JS; Lee ST; Chung HS; Kim SH; Park CJ; Chi HS; Im HJ; Seo JJ Haematologica; 2010 Apr; 95(4):622-6. PubMed ID: 20015888 [TBL] [Abstract][Full Text] [Related]
6. Mutations affecting mRNA splicing are the most common molecular defect in patients with familial hemophagocytic lymphohistiocytosis type 3. Santoro A; Cannella S; Trizzino A; Bruno G; De Fusco C; Notarangelo LD; Pende D; Griffiths GM; Aricò M Haematologica; 2008 Jul; 93(7):1086-90. PubMed ID: 18492689 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a large UNC13D gene duplication in a patient with familial hemophagocytic lymphohistiocytosis type 3. Hiejima E; Shibata H; Yasumi T; Shimodera S; Hori M; Izawa K; Kawai T; Matsuoka M; Kojima Y; Ohara A; Nishikomori R; Ohara O; Heike T Clin Immunol; 2018 Jun; 191():63-66. PubMed ID: 29596912 [TBL] [Abstract][Full Text] [Related]
8. Novel and atypical splicing mutation in a compound heterozygous UNC13D defect presenting in Familial Hemophagocytic Lymphohistiocytosis triggered by EBV infection. Alsina L; Colobran R; de Sevilla MF; Català A; Viñas L; Ricart S; Plaza AM; Lois S; Juan M; Pujol-Borrell R; Martinez-Gallo M Clin Immunol; 2014 Aug; 153(2):292-7. PubMed ID: 24825797 [TBL] [Abstract][Full Text] [Related]
9. Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis. Rudd E; Bryceson YT; Zheng C; Edner J; Wood SM; Ramme K; Gavhed S; Gürgey A; Hellebostad M; Bechensteen AG; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI J Med Genet; 2008 Mar; 45(3):134-41. PubMed ID: 17993578 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic challenges in a child with familial hemophagocytic lymphohistiocytosis type 3 (FHLH3) presenting with fulminant neurological disease. Weisfeld-Adams JD; Frank Y; Havalad V; Hojsak JM; Posada R; Kaicker SM; Wistinghausen B Childs Nerv Syst; 2009 Feb; 25(2):153-9. PubMed ID: 19023578 [TBL] [Abstract][Full Text] [Related]
11. A CD57 Hori M; Yasumi T; Shimodera S; Shibata H; Hiejima E; Oda H; Izawa K; Kawai T; Ishimura M; Nakano N; Shirakawa R; Nishikomori R; Takada H; Morita S; Horiuchi H; Ohara O; Ishii E; Heike T J Clin Immunol; 2017 Jan; 37(1):92-99. PubMed ID: 27896523 [TBL] [Abstract][Full Text] [Related]
12. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea. Seo JY; Song JS; Lee KO; Won HH; Kim JW; Kim SH; Lee SH; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Han DK; Kook H; Hwang TJ; Lyu CJ; Lee MJ; Kim JY; Park SS; Lim YT; Kim BE; Koh KN; Im HJ; Seo JJ; Kim HJ; Ann Hematol; 2013 Mar; 92(3):357-64. PubMed ID: 23180437 [TBL] [Abstract][Full Text] [Related]
13. Fatal sibling cases of familial hemophagocytic lymphohistiocytosis (FHL) with MUNC13-4 mutations: case reports. Nakao T; Shimizu T; Fukushima T; Saito M; Okamoto M; Sugiura M; Yamamoto K; Ueda I; Imashuku S; Kobayashi C; Koike K; Tsuchida M; Sumazaki R; Matsui A Pediatr Hematol Oncol; 2008; 25(3):171-80. PubMed ID: 18432499 [TBL] [Abstract][Full Text] [Related]